DrugPatentWatch Database Preview
Patent: 7,879,027
» See Plans and Pricing
Summary for Patent: 7,879,027
| Title: | Controlled release devices for fusion of osteal structures |
| Abstract: | A device includes a first reservoir configured to include a degradation agent, a first control element configured to provide access to the first reservoir, and an expandable component configured to extend to engage an osteal structure. |
| Inventor(s): | Trieu; Hai H. (Cordova, TN) |
| Assignee: | Warsaw Orthopedic, Inc. (N/A) |
| Application Number: | 11/517,771 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,879,027
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | Warsaw Orthopedic, Inc. (N/A) | 2026-04-24 | RX | search | |
| Discure Medical, Llc | CHYMODIACTIN | chymopapain | INJECTABLE;INJECTION | 018663 | 002 | 1984-07-09 | Start Trial | Warsaw Orthopedic, Inc. (N/A) | 2026-04-24 | DISCN | search | |
| Discure Medical, Llc | CHYMODIACTIN | chymopapain | INJECTABLE;INJECTION | 018663 | 001 | 1984-07-09 | Start Trial | Warsaw Orthopedic, Inc. (N/A) | 2026-04-24 | DISCN | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 7,879,027
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008030832 | Start Trial |
| United States of America | 2007250046 | Start Trial |
| United States of America | 2007276337 | Start Trial |
| United States of America | 7771414 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
